Skip to main content
. 2020 Oct 9;16(4):714–720. doi: 10.4103/1673-5374.295342

Figure 4.

Figure 4

Caveolin-1 is involved in dopaminergic-like neuronal differentiation of hADSCs.

(A) Confocal laser scanning microscopy of the change in Cav-1 expression during the differentiation of hADSCs into dopaminergic-like neurons. The nuclei are stained with Hoechst 33258 (blue), and Cav-1 (green) is stained with antibody to show its localization. (B, C) Western blot assay and quantitative analysis of the expression of Cav-1. (D, E) Polymerase chain reaction and quantitative analysis of the expression of Cav-1 during the dopaminergic-like neuronal differentiation of hADSCs at 14 and 29 days. ††P < 0.01, vs. ADSCs group. Data are presented as the mean ± SD (n = 3; one-way analysis of variance followed by least-significant difference post hoc test). Average of three independent in vitro differentiation experiments was calculated. Cav-1: Caveolin-1; hADSCs: human adipose-derived stem cells.